CCND1 and lung giant cell carcinoma: BBR inhibits AP‐1 signaling pathway activity and reduces the binding of transcription factors to the CCND1 AP‐1 motifs, which is an essential mechanism for the action of berberine as a cyclin‐D1 regulator against human lung giant cell carcinoma.197